Clinical Trials on Perforation Bowel in Czechia

Total 232 results

Faculty Hospital Kralovske Vinohrady
Charles University, Czech Republic

Recruiting

ILM Peeling Versus Inverted Flap Technique for Treatment of Macular Hole: Near Visual Acuity Outcomes

Macular Holes

Czechia
Thomayer University Hospital
Charles University, Czech Republic

Completed

Faecal Microbiota Transplantation in Irritable Bowel Syndrome (MISCEAT)

Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome Mixed

Czechia
Tomas Bata Hospital, Czech Republic
Faculty Hospital Kralovske Vinohrady

Recruiting

Oral Nano Vitamin D Supplementation Efficacy in Inflammatory Bowel Disease

Vitamin D Substitution

Czechia
Charles University, Czech Republic
University of Roma La Sapienza; University Of Perugia; Iscare i.v.f., Czech Republic and other collaborators

Active, not recruiting

The Effect of VSL#3 Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Czechia
Vitkovice Hospital

Completed

Carbon Dioxide Insufflation Colonoscopy in IBD Patients

Colonoscopy | Inflammatory Bowel Disease | Carbon Dioxide

Czech Republic
Vitkovice Hospital

Completed

Water-aided Colonoscopy in Inflammatory Bowel Disease Patients

Inflammatory Bowel Disease

Czech Republic
Ipsen

Completed

Eziclen Drug Utilisation in Real Life Setting (DUS-BLI800)

Bowel Cleansing

Netherlands, Czechia, Germany, Poland
Faculty Hospital Kralovske Vinohrady
Brno University Hospital; University Hospital, Motol; Nemocnice T.Bati, Zlin

Unknown

Impact of Time Intervals of Preparation on Quality and Tolerance of the Bowel Preparation

Colonoscopy | Bowel Preparation

Czech Republic
Faculty Hospital Kralovske Vinohrady
Brno University Hospital; Nemocnice T.Bati, Zlin

Unknown

Vitamin D Substitution During Winter Time

Vitamin D Substitution

Czech Republic
Ferring Pharmaceuticals

Completed

A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

Bowel Cleanliness

Czech Republic
Institute for Clinical and Experimental Medicine
Czech Academy of Sciences

Recruiting

Gluten-free Diet in PSC and IBD

Biliary Tract Diseases | Ulcerative Colitis | Primary Sclerosing Cholangitis | Intestinal Disease | Biliary Disease Tract

Czechia
Novartis Pharmaceuticals

Terminated

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

Russian Federation, Czechia, Bulgaria, Germany, Poland, Slovakia
University Hospital Ostrava

Completed

Intraoperative Haemodynamic Optimization Comparing Flow and Pressure Parameters (Flow-press)

Major Abdominal Surgery | Duodenohemipancreatectomy | Rectal Resection | Extensive Bowel Surgery

Czech Republic
Mitsubishi Tanabe Pharma Corporation

Completed

Extension Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Czechia, France, Germany, Hungary, Israel, Italy, Japan, Netherlands, Poland, Slovakia, Ukraine
The Faculty Hospital Na Bulovce

Completed

Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures

Small Bowel Obstruction | Acute Appendicitis | Perforated Gastroduodenal Ulcer

Czech Republic
Ferring Pharmaceuticals

Completed

A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease

Crohn's Disease

Czech Republic
Abivax S.A.

Active, not recruiting

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Czechia, Hungary
Ferring Pharmaceuticals

Terminated

Monitoring of Safety and Tolerance of PICOPREP in Clinical Practice

Bowel Cleanliness

Czech Republic
Faculty Hospital Kralovske Vinohrady

Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Infections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditions

Czechia
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
Ionis Pharmaceuticals, Inc.

Completed

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Crohn's Disease

Poland, Spain, Belgium, Germany, Czechia, Italy
Institute for Clinical and Experimental Medicine
Institute of Animal Physiology and Genetics Academy of Science Czech Republic

Completed

Faecal Bacteriotherapy for Ulcerative Colitis (FACTU)

Ulcerative Colitis

Czechia
Gilead Sciences
Galapagos NV

Completed

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) (DIVERGENCE 1)

Small Bowel Crohn's Disease

United States, Belgium, United Kingdom, Germany, Spain, Czechia, Canada, Austria, France, Hungary, Italy, Ukraine
GLSMED Learning Health S.A.
AbbVie

Recruiting

The CROCO Study: CROhn's Disease COhort Study (CROCO)

Crohn Disease

Spain, Italy, Denmark, Belgium, Cyprus, Czechia, France, Malta, Portugal, Romania, United Kingdom
Ondrej Ryska

Unknown

Early Surgery Versus Conservative Treatment in Patients With Ileocaecal Crohn's Disease (ESPRIT)

Crohn's Disease

Czech Republic
Mitsubishi Tanabe Pharma Corporation

Completed

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Crohn's Disease

France, Israel, Italy, Netherlands, Poland, Slovakia, Ukraine, Czech Republic, Germany, Hungary, Japan
Kyowa Kirin, Inc.

Completed

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

Digestive System Diseases | Gastrointestinal Diseases | Colonic Diseases | Intestinal Diseases | Abdominal Pain | Inflammatory Bowel Diseases | Ulcerative Colitis | Colitis | Colitis, Ulcerative | Autoimmune Disease

Hungary, Russian Federation, Serbia, United States, Poland, Czechia, Romania
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease (CONNECT-IBD)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis

France, Spain, United Kingdom, Czechia, Italy, Belgium, Germany, Netherlands, Greece, Finland, Hungary, Portugal, Slovakia
Toray Industries, Inc

Completed

A Study of TRK-170 for the Treatment of Crohn's Disease

Crohn's Disease

Bulgaria, France, Hungary, Belgium, Czech Republic, Latvia, Netherlands, Norway, Poland, Romania, Serbia, Sweden, Ukraine
Morphic Therapeutic, Inc

Recruiting

A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC (EMERALD-2)

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Germany, Korea, Republic of, Italy, Poland, Australia, Georgia, Austria, Bulgaria, Czechia, Estonia, France, Hungary, India, Israel, Latvia, Lithuania, Romania, Serbia, Slovakia, Taiwan
Universitaire Ziekenhuizen KU Leuven
International organization for the study of inflammatory bowel disease (IOIBD)

Terminated

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

Recurrence | Crohn Disease | Prevention | Azathioprine

Belgium, Greece, Czech Republic
Ocera Therapeutics

Completed

Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas

Intestinal Fistula | Inflammatory Bowel Disease

United States, Israel, Canada, United Kingdom, Germany, Belgium, Hungary, France, Austria, Czech Republic, Netherlands, Poland
Abivax S.A.

Completed

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Spain, France, Belgium, Poland, Hungary, Austria, Czechia, Germany
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UNIFI)

Inflammatory Bowel Diseases | Colitis, Ulcerative

United States, Australia, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Israel, Bulgaria, Romania, Serbia, Japan, Canada, Netherlands, Korea, Republic of, New Zealand, Russian Federation, Austria, Hungary, Slovakia, D... and more
EA Pharma Co., Ltd.

Active, not recruiting

A Study of E6011 in Participants With Active Crohn's Disease

Crohn's Disease

Czechia, Hungary, Japan, Poland, Russian Federation
Celltrion

Completed

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)

Crohn's Disease

France, Turkey, Czechia, Greece, Latvia, Hungary, Belarus, Israel, United States, Spain, Bulgaria, Serbia, Croatia, Italy, Germany, India, Japan, Mexico, Moldova, Republic of, Peru, Poland, Romania, Russian Federation, Slovakia, South Africa and more
Prometheus Biosciences, Inc., a subsidiary of Merck...

Active, not recruiting

A Phase 2a Safety and Efficacy Open-Label Study of PRA023 in Subjects With Moderately to Severely Active Crohn's Disease (APOLLO-CD)

Crohn Disease

United States, Australia, Belgium, Canada, Czechia, France, Georgia, Poland
Topivert Pharma Ltd

Completed

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (TOP2)

Ulcerative Colitis

Poland, Ukraine, United Kingdom, Bulgaria, Hungary, Lithuania, Czechia, Latvia
InDex Pharmaceuticals

Completed

The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients (COLLECT)

Colitis, Ulcerative

Czechia, France, Germany, Hungary, Italy, Poland, United Kingdom
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Crohn's Disease | Colitis | Inflammatory Bowel Disease | IBD

United States, France, Poland, United Kingdom, Germany, Spain, Israel, Bulgaria, Serbia, South Africa, Japan, Canada, Australia, Netherlands, Korea, Republic of, Belgium, New Zealand, Brazil, Russian Federation, Austria, Hungary, ... and more
AM-Pharma
CRM Biometrics GmbH; Sintesi Research Srl; Vigilex BV

Completed

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Czech Republic, Italy
Sucampo Pharma Americas, LLC
Sucampo Pharmaceuticals, Inc.

Completed

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

Opioid-induced Bowel Dysfunction

United States, Czechia, Germany, Belgium, Poland, Sweden, United Kingdom
Asahi Kasei Medical Co., Ltd.
Asahi Kasei Medical Europe GmbH

Terminated

A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Ulcerative Colitis

United Kingdom, Japan, Germany, Sweden, Israel, Czech Republic
Menarini Group

Completed

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) (IRIS-2)

Irritable Bowel Syndrome With Diarrhea

Poland, Germany, Spain, Denmark, Bulgaria, Czech Republic, Italy, Sweden
Boehringer Ingelheim

Active, not recruiting

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

Crohn Disease

United States, Belgium, Germany, Hungary, Spain, United Kingdom, Denmark, Czechia, Poland, Italy, Netherlands
Galapagos NV

Completed

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

Ulcerative Colitis

Belgium, Czech Republic, Slovakia, Latvia
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Crohn's Disease | Colitis | Inflammatory Bowel Disease | IBD

United States, France, Poland, United Kingdom, Germany, Spain, Serbia, South Africa, Japan, Israel, Canada, Australia, Netherlands, Korea, Republic of, Belgium, New Zealand, Brazil, Austria, Ireland, Czech Republic, Hungary, Denmark, Icela...
Lycera Corp.

Terminated

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Colitis, Ulcerative

United States, Czechia, Hungary, Netherlands, Poland, Serbia
Neovacs

Completed

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Crohn's Disease

Germany, Belgium, France, Romania, Bulgaria, Croatia, Czech Republic, Hungary, Netherlands
Pfizer

Completed

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Crohn's Disease

Korea, Republic of, United States, Spain, Netherlands, Australia, Israel, Canada, Czechia, Japan, Germany, Hungary, Austria, Bulgaria, Greece, South Africa, Ukraine, France

Clinical Trials on Perforation Bowel in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations